PMID- 27417010
OWN - NLM
STAT- MEDLINE
DCOM- 20170630
LR  - 20180920
IS  - 1558-3597 (Electronic)
IS  - 0735-1097 (Linking)
VI  - 68
IP  - 3
DP  - 2016 Jul 19
TI  - Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC 
      Guidelines.
PG  - 313-321
LID - S0735-1097(16)33129-1 [pii]
LID - 10.1016/j.jacc.2016.03.599 [doi]
AB  - Non-ST-segment elevation acute coronary syndromes (NSTE-ACS) are the leading 
      cause of morbidity and mortality from cardiovascular disease worldwide. The 
      American Heart Association/American College of Cardiology and the European 
      Society of Cardiology periodically release practice guidelines to guide 
      clinicians in the management of NSTE-ACS, most recently in in 2014 and 2015, 
      respectively. The present review compares and contrasts the 2 guidelines, with a 
      focus on the strength of recommendation and level of evidence in the approach to 
      initial presentation and diagnosis of NSTE-ACS, risk assessment, treatments, and 
      systems of care. Important differences include the use of a rapid rule-out 
      protocol with high-sensitivity troponin assays, a preference for 
      prasugrel/ticagrelor and fondaparinux for anticoagulation therapy, and a 
      preference for radial arterial access in the European Society of Cardiology 
      guidelines compared with the American Heart Association/American College of 
      Cardiology guidelines. We also highlight the similarities and differences in the 
      guidelines for special patient populations and suggest areas of further study.
CI  - Copyright (c) 2016 American College of Cardiology Foundation. Published by Elsevier 
      Inc. All rights reserved.
FAU - Rodriguez, Fatima
AU  - Rodriguez F
AD  - Stanford University School of Medicine, Department of Medicine, Division of 
      Cardiovascular Medicine, Stanford, California.
FAU - Mahaffey, Kenneth W
AU  - Mahaffey KW
AD  - Stanford University School of Medicine, Department of Medicine, Division of 
      Cardiovascular Medicine, Stanford, California. Electronic address: 
      kenneth.mahaffey@stanford.edu.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - J Am Coll Cardiol
JT  - Journal of the American College of Cardiology
JID - 8301365
RN  - 0 (Anticoagulants)
RN  - 0 (Platelet Aggregation Inhibitors)
SB  - IM
MH  - Acute Coronary Syndrome/*therapy
MH  - Anticoagulants/*therapeutic use
MH  - Cardiology/*methods
MH  - *Electrocardiography
MH  - Europe
MH  - Platelet Aggregation Inhibitors/*therapeutic use
MH  - *Practice Guidelines as Topic
MH  - *Societies, Medical
MH  - United States
OTO - NOTNLM
OT  - acute coronary syndrome
OT  - anticoagulants
OT  - antiplatelet
OT  - quality of care
OT  - risk assessment
EDAT- 2016/07/16 06:00
MHDA- 2017/07/01 06:00
CRDT- 2016/07/16 06:00
PHST- 2015/12/10 00:00 [received]
PHST- 2016/02/25 00:00 [revised]
PHST- 2016/03/01 00:00 [accepted]
PHST- 2016/07/16 06:00 [entrez]
PHST- 2016/07/16 06:00 [pubmed]
PHST- 2017/07/01 06:00 [medline]
AID - S0735-1097(16)33129-1 [pii]
AID - 10.1016/j.jacc.2016.03.599 [doi]
PST - ppublish
SO  - J Am Coll Cardiol. 2016 Jul 19;68(3):313-321. doi: 10.1016/j.jacc.2016.03.599.